메뉴 건너뛰기




Volumn 24, Issue 7, 2013, Pages 1822-1827

ROS1 fusions in Chinese patients with non-small-cell lung cancer

Author keywords

Fusion; Non small cell lung cancer; Oncogenic driver; Rearrangement; ROS1

Indexed keywords

RNA;

EID: 84883444507     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt071     Document Type: Article
Times cited : (81)

References (26)
  • 2
    • 78049485263 scopus 로고    scopus 로고
    • Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
    • Ferlay J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
    • (2010) Int J Cancer , vol.127 , pp. 2893-2917
    • Ferlay, J.1    Shin, H.R.2    Bray, F.3
  • 3
    • 69949162760 scopus 로고    scopus 로고
    • Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma
    • Mok TS, Wu YL, Thongprasert S et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009; 361: 947-957.
    • (2009) N Engl J Med , vol.361 , pp. 947-957
    • Mok, T.S.1    Wu, Y.L.2    Thongprasert, S.3
  • 4
    • 79960889662 scopus 로고    scopus 로고
    • Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase3 study
    • Zhou C, Wu YL, Chen G et al. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase3 study. Lancet Oncol 2011; 12: 735-742.
    • (2011) Lancet Oncol , vol.12 , pp. 735-742
    • Zhou, C.1    Wu, Y.L.2    Chen, G.3
  • 5
    • 34547638047 scopus 로고    scopus 로고
    • Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
    • Soda M, Choi YL, Enomoto M et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007; 448: 561-566.
    • (2007) Nature , vol.448 , pp. 561-566
    • Soda, M.1    Choi, Y.L.2    Enomoto, M.3
  • 6
    • 84863338079 scopus 로고    scopus 로고
    • ROS1 rearrangements define a unique molecular class of lung cancers
    • Bergethon K, Shaw AT, Ou SH et al. ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol 2012; 30: 863-870.
    • (2012) J Clin Oncol , vol.30 , pp. 863-870
    • Bergethon, K.1    Shaw, A.T.2    Ou, S.H.3
  • 7
    • 84857929267 scopus 로고    scopus 로고
    • KIF5B-RET fusions in lung adenocarcinoma
    • Kohno T, Ichikawa H, Totoki Y et al. KIF5B-RET fusions in lung adenocarcinoma. Nat Med 2012; 18: 375-377.
    • (2012) Nat Med , vol.18 , pp. 375-377
    • Kohno, T.1    Ichikawa, H.2    Totoki, Y.3
  • 8
    • 2342471392 scopus 로고    scopus 로고
    • Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
    • Lynch TJ, Bell DW, Sordella R et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004; 350: 2129-2139.
    • (2004) N Engl J Med , vol.350 , pp. 2129-2139
    • Lynch, T.J.1    Bell, D.W.2    Sordella, R.3
  • 9
    • 80052806086 scopus 로고    scopus 로고
    • Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)
    • Cui JJ, Tran-Dube M, Shen H et al. Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK). J Med Chem 2011; 54: 6342-6363.
    • (2011) J Med Chem , vol.54 , pp. 6342-6363
    • Cui, J.J.1    Tran-Dube, M.2    Shen, H.3
  • 10
    • 44849126091 scopus 로고    scopus 로고
    • Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors
    • McDermott U, Iafrate AJ, Gray NS et al. Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors. Cancer Res 2008; 68: 3389-3395.
    • (2008) Cancer Res , vol.68 , pp. 3389-3395
    • McDermott, U.1    Iafrate, A.J.2    Gray, N.S.3
  • 11
    • 78049425319 scopus 로고    scopus 로고
    • Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer
    • Kwak EL, Bang YJ, Camidge DR et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010; 363: 1693-1703.
    • (2010) N Engl J Med , vol.363 , pp. 1693-1703
    • Kwak, E.L.1    Bang, Y.J.2    Camidge, D.R.3
  • 12
    • 84857985225 scopus 로고    scopus 로고
    • RET, ROS1 and ALK fusions in lung cancer
    • Takeuchi K, Soda M, Togashi Y et al. RET, ROS1 and ALK fusions in lung cancer. Nat Med 2012; 18: 378-381.
    • (2012) Nat Med , vol.18 , pp. 378-381
    • Takeuchi, K.1    Soda, M.2    Togashi, Y.3
  • 13
    • 84865441368 scopus 로고    scopus 로고
    • Identifying and targeting ROS1 gene fusions in non-small cell lung cancer
    • Davies KD, Le AT, Theodoro MF et al. Identifying and targeting ROS1 gene fusions in non-small cell lung cancer. Clin Cancer Res 2012; 18: 4570-4579.
    • (2012) Clin Cancer Res , vol.18 , pp. 4570-4579
    • Davies, K.D.1    Le, A.T.2    Theodoro, M.F.3
  • 14
    • 0023477402 scopus 로고
    • Expression and rearrangement of the ROS1 gene in human glioblastoma cells
    • Birchmeier C, Sharma S, Wigler M. Expression and rearrangement of the ROS1 gene in human glioblastoma cells. Proc Natl Acad Sci USA 1987; 84: 9270-9274.
    • (1987) Proc Natl Acad Sci USA , vol.84 , pp. 9270-9274
    • Birchmeier, C.1    Sharma, S.2    Wigler, M.3
  • 15
    • 33747189468 scopus 로고    scopus 로고
    • A prospective replication study of five gene variants previously associated with risk of myocardial infarction
    • Zee RY, Michaud SE, Hegener HH et al. A prospective replication study of five gene variants previously associated with risk of myocardial infarction. J Thromb Haemost 2006; 4: 2093-2095.
    • (2006) J Thromb Haemost , vol.4 , pp. 2093-2095
    • Zee, R.Y.1    Michaud, S.E.2    Hegener, H.H.3
  • 16
    • 36849065315 scopus 로고    scopus 로고
    • Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer
    • Rikova K, Guo A, Zeng Q et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007; 131: 1190-1203.
    • (2007) Cell , vol.131 , pp. 1190-1203
    • Rikova, K.1    Guo, A.2    Zeng, Q.3
  • 17
    • 79251579592 scopus 로고    scopus 로고
    • Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma
    • Gu TL, Deng X, Huang F et al. Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS One 2011; 6: e15640.
    • (2011) PLoS One , vol.6
    • Gu, T.L.1    Deng, X.2    Huang, F.3
  • 18
    • 82755170504 scopus 로고    scopus 로고
    • Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours
    • Birch AH, Arcand SL, Oros KK et al. Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours. PLoS One 2011; 6: e28250.
    • (2011) PLoS One , vol.6
    • Birch, A.H.1    Arcand, S.L.2    Oros, K.K.3
  • 19
    • 79551538094 scopus 로고    scopus 로고
    • Frequencies of ALK and ROS in NSCLC FFPE tumor samples utilizing a highly specific immunohistochemistry-based assay and FISH analysis
    • abstr 10536
    • Rimkunas V, Crosby K, Kelly M et al. Frequencies of ALK and ROS in NSCLC FFPE tumor samples utilizing a highly specific immunohistochemistry-based assay and FISH analysis. J Clin Oncol 2010; 28: 15s (suppl; abstr 10536).
    • (2010) J Clin Oncol , vol.28 , Issue.SUPPL
    • Rimkunas, V.1    Crosby, K.2    Kelly, M.3
  • 20
    • 84865089246 scopus 로고    scopus 로고
    • Analysis of receptor tyrosine kinase ROS1- positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusion
    • Rimkunas VM, Crosby KE, Li D et al. Analysis of receptor tyrosine kinase ROS1- positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusion. Clin Cancer Res 2012; 18: 4449-4457.
    • (2012) Clin Cancer Res , vol.18 , pp. 4449-4457
    • Rimkunas, V.M.1    Crosby, K.E.2    Li, D.3
  • 21
    • 84866434919 scopus 로고    scopus 로고
    • Genomic landscape of non-small cell lung cancer in smokers and never-smokers
    • Govindan R, Ding L, Griffith M et al. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 2012; 150: 1121-1134.
    • (2012) Cell , vol.150 , pp. 1121-1134
    • Govindan, R.1    Ding, L.2    Griffith, M.3
  • 22
    • 84868309107 scopus 로고    scopus 로고
    • The transcriptional landscape and mutational profile of lung adenocarcinoma
    • Seo JS, Ju YS, Lee WC et al. The transcriptional landscape and mutational profile of lung adenocarcinoma. Genome Res 2012; 22: 2109-2119.
    • (2012) Genome Res , vol.22 , pp. 2109-2119
    • Seo, J.S.1    Ju, Y.S.2    Lee, W.C.3
  • 23
    • 84873697461 scopus 로고    scopus 로고
    • Prevalence and clinical outcomes for patients with ALK gene rearrangement in Europe: preliminary results from the European Thoracic Oncology Platform Lungscape Project
    • (abstr 167O)
    • Blackhall F, Peters S, Ken KM et al. Prevalence and clinical outcomes for patients with ALK gene rearrangement in Europe: preliminary results from the European Thoracic Oncology Platform Lungscape Project. Ann Oncol 2012; 23 (suppl 9): ix73 (abstr 167O).
    • (2012) Ann Oncol , vol.23 , Issue.SUPPL 9
    • Blackhall, F.1    Peters, S.2    Ken, K.M.3
  • 24
    • 82355161909 scopus 로고    scopus 로고
    • Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers
    • Li C, Fang R, Sun Y et al. Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers. PLoS One 2011; 6: e28204.
    • (2011) PLoS One , vol.6
    • Li, C.1    Fang, R.2    Sun, Y.3
  • 25
    • 84871784888 scopus 로고    scopus 로고
    • ROS1 receptor tyrosine kinase, a druggable target, is frequently overexpressed in non-small cell lung carcinomas via genetic and epigenetic mechanisms
    • Lee HJ, Seol HS, Kim JY et al. ROS1 receptor tyrosine kinase, a druggable target, is frequently overexpressed in non-small cell lung carcinomas via genetic and epigenetic mechanisms. Ann Surg Oncol 2013; 20: 200-208.
    • (2013) Ann Surg Oncol , vol.20 , pp. 200-208
    • Lee, H.J.1    Seol, H.S.2    Kim, J.Y.3
  • 26
    • 84866894408 scopus 로고    scopus 로고
    • Comprehensive genomic characterization of squamous cell lung cancers
    • Hammerman PS, Hayes DN, Wilkerson MD et al. Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012; 489: 519-525.
    • (2012) Nature , vol.489 , pp. 519-525
    • Hammerman, P.S.1    Hayes, D.N.2    Wilkerson, M.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.